GlassScriptPhysician profile
Kimberly J Hogan
NPI 1912310509
$4,418.20
in general payments reported to CMS, 2019-2025
30 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,374 · 2022: $832 · 2023: $1,009 · 2024: $756 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,212.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $734.07 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $561.65 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $368.88 | 2021-2024 | |
| Abbvie INC. | $354.74 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $340.53 | 2021-2025 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Lilly USA, LLC | $313.30 | 2021-2025 | Jardiance, Mounjaro, Emgality |
| Amarin Pharma, INC. | $262.54 | 2021-2022 | |
| Amgen INC. | $223.88 | 2021-2024 | Repatha, Otezla, Prolia |
| Janssen Pharmaceuticals, INC | $221.79 | 2021-2024 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $153.42 | 2021-2025 | Seglentis, Zoryve |
| Astellas Pharma US INC | $129.13 | 2021 | |
| Novartis Pharmaceuticals Corporation | $99.10 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $91.35 | 2021-2024 | Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.52 | 2021-2025 | Xifaxan |
| Boston Scientific Corporation | $72.67 | 2023-2024 | Watchman Flx |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $50.19 | 2023 | Quviviq |
| Exact Sciences Corporation | $47.94 | 2023-2024 | Cologuard Collection Kit |
| Almatica Pharma LLC | $45.29 | 2021-2023 | Loreev Xr, Gralise |
| Bayer Healthcare Pharmaceuticals INC. | $44.64 | 2021 | |
| Sunovion Pharmaceuticals INC. | $39.15 | 2021 | |
| Sumitomo Pharma America, INC. | $24.66 | 2025 | Gemtesa |
| Scilex Pharmaceuticals INC. | $23.04 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.30 | 2021 | |
| Genzyme Corporation | $17.95 | 2021 | |
| Lundbeck LLC | $17.01 | 2025 | Vyepti |
| Corcept Therapeutics | $16.89 | 2025 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $16.45 | 2022 | |
| Horizon Therapeutics Plc | $15.66 | 2023 | Krystexxa |
| Medtronic, INC. | $15.64 | 2025 | Venaseal |
| Takeda Pharmaceuticals U.S.A., INC. | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.